Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CXCR4 | P61073 | 5/20 | 0.59 |
| ▸ | ITGB3 | P05106 | 11/20 | 0.47 |
| ▸ | ITGAV | P06756 | 11/20 | 0.47 |
| ▸ | ITGB6 | P18564 | 9/20 | 0.47 |
| ▸ | ITGB5 | P18084 | 1/20 | 0.47 |
| ▸ | ITGB8 | P26012 | 1/20 | 0.47 |
| ▸ | ITGB1 | P05556 | 3/20 | 0.45 |
| ▸ | ITGA4 | P13612 | 1/20 | 0.45 |
| ▸ | CCR2 | P41597 | 2/20 | 0.45 |
| ▸ | ITGA5 | P08648 | 2/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13355165 | 0.91 | CXCR4 (0.61) | CXCR4ITGB3ITGAVITGB6ITGB5 | |
| SCHEMBL13355159 | 0.90 | CXCR4 (0.60) | CXCR4ITGB3ITGAVITGB6ITGB5 | |
| SCHEMBL13355215 | 0.90 | CXCR4 (0.59) | CXCR4ITGB3ITGAVITGB6ITGB5 | |
| SCHEMBL13355158 | 0.85 | CXCR4 (0.65) | CXCR4ITGB3ITGAVITGB6ITGB5 | |
| SCHEMBL13355380 | 0.85 | CXCR4 (0.68) | CXCR4ITGB3ITGAVITGB6ITGB5 | |
| SCHEMBL13355168 | 0.82 | CXCR4 (0.60) | CXCR4ITGB3ITGAVITGB6ITGB5 | |
| SCHEMBL13355162 | 0.82 | CXCR4 (0.67) | CXCR4ITGB3ITGAVITGB6ITGB5 | |
| SCHEMBL13355219 | 0.81 | CXCR4 (0.57) | CXCR4ITGB3ITGAVITGB6ITGB5 | |
| SCHEMBL13355220 | 0.81 | CXCR4 (0.56) | CXCR4ITGB3ITGAVITGB6ITGB5 | |
| SCHEMBL13355413 | 0.80 | CXCR4 (0.69) | CXCR4ITGB3ITGAVITGB6ITGB5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2010057101-A2 | COMPOUNDS USEFUL AS HIV BLOCKERS | SCHERING CORPORATION (US) | 2010-05-20 | — | — | WO | disclosed |